<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective AnalysisJustin F. Gainor, Mari Mino–Kenudson, Beow Y. Yeap et al.|Clinical Cancer Research|2016Cited by 1.2k
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung CancerAnna F. Farago, Benjamin J. Drapkin, Beow Y. Yeap et al.|Cancer Discovery|2019Cited by 238
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived XenograftsBenjamin J. Drapkin, Anna F. Farago, Julie George et al.|Cancer Discovery|2018Cited by 216
Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12CAndreas Weiss, Saskia M. Brachmann, Edwige Lorthiois et al.|Cancer Discovery|2022Cited by 134
Gene Expression Profiling Reveals Progesterone-Mediated Cell Cycle and Immunoregulatory Roles of Hoxa-10 in the Preimplantation UterusMylene Yao, Richard L. Maas, Hyunjung Jade Lim et al.|Molecular Endocrinology|2003Cited by 98